The global veterinary infectious disease diagnostics market is poised for remarkable expansion, projected to reach USD 4.22 billion by 2030 from USD 2.87 billion in 2025, growing at a CAGR of 8.0% during the forecast period.
According to the latest report, “Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostics, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region – Global Forecast to 2030”, this market’s evolution is being shaped by technological innovation, growing disease awareness, and increased spending on animal health worldwide.
Market Overview: A Growing Need for Precision Diagnostics
The market is experiencing significant growth, largely driven by the rising prevalence of infectious diseases among both companion and livestock animals. As zoonotic diseases continue to pose threats to public health and the global food supply, veterinarians and livestock producers are investing heavily in advanced diagnostic technologies to enhance early detection and control of infections.
In addition, the economic impact of animal disease outbreaks has encouraged governments and private organizations to strengthen disease surveillance systems and testing infrastructure. Early and accurate diagnosis not only mitigates transmission but also reduces treatment costs and ensures animal welfare — making diagnostics a cornerstone of modern veterinary healthcare.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584
Consumables Lead the Market by Product Segment
In 2024, consumables — including diagnostic kits, reagents, and other testing materials — accounted for the largest share of the veterinary infectious disease diagnostics market.
Their recurring nature and high turnover make them indispensable for laboratories, clinics, and point-of-care settings. As the frequency of diagnostic testing increases, particularly in preventive care and outbreak management, the demand for consumables continues to surge.
Unlike instruments that are one-time purchases, consumables generate sustained revenue streams, making them a strategic focus area for diagnostic manufacturers seeking consistent market growth.
Molecular Diagnostics: The Fastest-Growing Technology Segment
The molecular diagnostics segment is expected to register the highest CAGR during the forecast period, driven by its superior accuracy, speed, and sensitivity.
Technologies such as polymerase chain reaction (PCR), real-time PCR (qPCR), and nucleic acid sequencing enable early and precise detection of infectious pathogens, even at minimal concentrations.
With the growing complexity of animal diseases — particularly emerging and re-emerging infectious agents — molecular assays are rapidly becoming the gold standard for veterinary diagnostics. Their ability to deliver rapid, actionable results is transforming clinical decision-making and improving treatment outcomes across veterinary settings.
Regional Insights: North America Dominates the Global Landscape
In 2024, North America emerged as the largest regional market for veterinary infectious disease diagnostics.
Several factors contribute to this leadership:
- Well-established veterinary healthcare infrastructure
- Presence of leading diagnostic manufacturers such as IDEXX Laboratories, Zoetis, and Thermo Fisher Scientific
- High pet ownership rates and insurance coverage
- Strong awareness of preventive care and zoonotic disease management
Moreover, ongoing government initiatives to control animal-borne infections and enhance surveillance systems further strengthen the region’s position in the global market.
Key Industry Players
Major companies shaping the competitive landscape include:
- IDEXX Laboratories, Inc. (US)
- Zoetis Services LLC (US)
- Thermo Fisher Scientific Inc. (US)
- Virbac (France)
- bioMérieux (France)
- Antech Diagnostics, Inc. (US)
- Innovative Diagnostics (France)
- Neogen Corporation (US)
- INDICAL BIOSCIENCE GmbH (Germany)
- Agrolabo S.p.A. (Italy)
These players are focusing on strategic partnerships, technological advancements, and product portfolio expansion to enhance diagnostic efficiency and accessibility worldwide.
Conclusion: The Road Ahead for Veterinary Diagnostics
As the global demand for efficient animal health management grows, the veterinary infectious disease diagnostics market is set to play a pivotal role in shaping the future of veterinary medicine.
With continuous innovation in molecular and immunodiagnostic technologies, expanding veterinary care networks, and rising awareness among animal owners, the market’s growth trajectory is expected to accelerate even further — ensuring healthier animals, safer food chains, and stronger disease resilience worldwide.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=221816584